News

Scientists have solved a decade-old mystery that could eventually lead to the development of earlier treatments for one of the world’s deadliest diseases, which affects up to 2 billion people.

A new mapping by the University of Copenhagen and Uppsala University of all these drugs on the market and currently tested in clinical trials has been published in the prestigious journal Nature Reviews Drug Discovery.

Innovative and relevant models for understanding alpha-synuclein biology and Parkinson’s disease pathogenesis in vivo.

A new statistical model has enabled researchers to pinpoint 27 novel genes thought to prevent cancer from forming, in an analysis of over 2000 tumours across 12 human cancer types.

A preclinical study led by Indiana University scientists reports a promising step forward in the search for pain relief methods without the addictive side effects behind the country's current opioid addiction crisis.

According to a new study from scientists at The Scripps Research Institute (TSRI), the common practice of growing influenza vaccine components in chicken eggs disrupts the major antibody target site on the virus surface, rendering the flu vaccine less effective in humans.

The California Department of Public Health issued more alerts for lead in candy than for the other top three sources of food-borne contamination combined a study found.

Scientists have analyzed cultivated potatoes and their wild relatives using modern genomics approaches to reveal key factors that could address food security in 21st century agriculture.

A study led by scientists from Harvard Medical School reveals “hidden” variability in how tumor cells are affected by anticancer drugs, offering new insights on why patients with the same form of cancer can have different responses to a drug.

Researchers have produced the first three-dimensional (3D) map of a molecular 'scaffold' called SgK223, known to play a critical role in the development and spread of aggressive breast, colon and pancreatic cancers.